OSU-03012 Disrupts Akt Signaling and Prevents Endometrial Carcinoma Progression in vitro and in vivo

PURPOSE: OSU-03012 is a celecoxib derivative lacking cyclooxygenase-2 inhibitory activity and a potent PDK1 inhibitor which has been shown to inhibit tumor growth in various ways. However, the role of OSU-03012 in endometrial carcinoma (EC) in which the PI3K/Akt signaling pathway highly activated ha...

Descripción completa

Detalles Bibliográficos
Autores principales: Ding, Leilei, Ren, Chenchen, Yang, Li, Wu, Zimeng, Li, Feiyan, Jiang, Dongyuan, Zhu, Yuanhang, Lu, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096345/
https://www.ncbi.nlm.nih.gov/pubmed/33958857
http://dx.doi.org/10.2147/DDDT.S304128

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8096345/
https://www.ncbi.nlm.nih.gov/pubmed/33958857
http://dx.doi.org/10.2147/DDDT.S304128

Ejemplares similares